Shopping Cart 0
Cart Subtotal
AED 0

Bachem Holding AG (BANB) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

Bachem Holding AG (BANB)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers products and services to the pharmaceutical and biotechnology industries. Its research products include biologically active peptides, amino acid derivatives, biochemicals and immunology products. These products and services include peptides; research ingredients; new chemical entities; and generics indicated for the treatment of various conditions such as central nervous system disorders, metabolic disorders, cancer and infectious diseases, among others. The company operates production facilities in the US and Europe. Bachem is headquartered in Bubendorf, Switzerland.

Bachem Holding AG Key Recent Developments

Mar 08,2019: Bachem 2018 fiscal year: record sales and increased operating income

Nov 21,2018: Bachem Appoints Thomas Meier as COO

Oct 26,2018: Thomas Meier to become new COO of Bachem Group

Aug 24,2018: Bachem-first half of 2018: further rise in the net profit

Jul 20,2018: Bachem: Footprint in Asia

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Bachem Holding AG-Key Facts

Bachem Holding AG-Key Employees

Bachem Holding AG-Key Employee Biographies

Bachem Holding AG-Major Products and Services

Bachem Holding AG-History

Bachem Holding AG-Company Statement

Bachem Holding AG-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Bachem Holding AG-Business Description

Business Segment: Active Pharmaceutical Ingredients

Overview

Performance

Business Segment: Research Chemicals

Overview

Performance

Geographical Segment: Germany

Performance

Geographical Segment: Great Britain

Performance

Geographical Segment: Japan

Performance

Geographical Segment: Rest of the World

Performance

Geographical Segment: Switzerland

Performance

Geographical Segment: USA

Performance

Bachem Holding AG-SWOT Analysis

SWOT Analysis-Overview

Bachem Holding AG-Strengths

Bachem Holding AG-Weaknesses

Bachem Holding AG-Opportunities

Bachem Holding AG-Threats

Bachem Holding AG-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Bachem Holding AG, Recent Deals Summary

Section 5-Company's Recent Developments

Mar 08, 2019: Bachem 2018 fiscal year: record sales and increased operating income

Nov 21, 2018: Bachem Appoints Thomas Meier as COO

Oct 26, 2018: Thomas Meier to become new COO of Bachem Group

Aug 24, 2018: Bachem-first half of 2018: further rise in the net profit

Jul 20, 2018: Bachem: Footprint in Asia

May 04, 2018: Bachem Site in St Helens, Uk, Obtains ISO Certification

Mar 16, 2018: Bachem: Fiscal year 2017-Continued increase in sales, profitability and earnings

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Bachem Holding AG, Performance Chart (2014-2018)

Bachem Holding AG, Ratio Charts

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Bachem Holding AG, Key Facts

Bachem Holding AG, Key Employees

Bachem Holding AG, Key Employee Biographies

Bachem Holding AG, Major Products and Services

Bachem Holding AG, History

Bachem Holding AG, Subsidiaries

Bachem Holding AG, Key Competitors

Bachem Holding AG, Ratios based on current share price

Bachem Holding AG, Annual Ratios

Bachem Holding AG, Annual Ratios (Cont...1)

Bachem Holding AG, Annual Ratios (Cont...2)

Bachem Holding AG, Interim Ratios

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Bachem Holding AG, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Bachem Holding AG, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Clariant International Ltd

Bio-Gate Ag

Mymetics Corp

Celltrion Inc

Company Profile

Company Profile Title

Bachem Holding AG (BANB)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers products and services to the pharmaceutical and biotechnology industries. Its research products include biologically active peptides, amino acid derivatives, biochemicals and immunology products. These products and services include peptides; research ingredients; new chemical entities; and generics indicated for the treatment of various conditions such as central nervous system disorders, metabolic disorders, cancer and infectious diseases, among others. The company operates production facilities in the US and Europe. Bachem is headquartered in Bubendorf, Switzerland.

Bachem Holding AG Key Recent Developments

Mar 08,2019: Bachem 2018 fiscal year: record sales and increased operating income

Nov 21,2018: Bachem Appoints Thomas Meier as COO

Oct 26,2018: Thomas Meier to become new COO of Bachem Group

Aug 24,2018: Bachem-first half of 2018: further rise in the net profit

Jul 20,2018: Bachem: Footprint in Asia

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Bachem Holding AG-Key Facts

Bachem Holding AG-Key Employees

Bachem Holding AG-Key Employee Biographies

Bachem Holding AG-Major Products and Services

Bachem Holding AG-History

Bachem Holding AG-Company Statement

Bachem Holding AG-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Bachem Holding AG-Business Description

Business Segment: Active Pharmaceutical Ingredients

Overview

Performance

Business Segment: Research Chemicals

Overview

Performance

Geographical Segment: Germany

Performance

Geographical Segment: Great Britain

Performance

Geographical Segment: Japan

Performance

Geographical Segment: Rest of the World

Performance

Geographical Segment: Switzerland

Performance

Geographical Segment: USA

Performance

Bachem Holding AG-SWOT Analysis

SWOT Analysis-Overview

Bachem Holding AG-Strengths

Bachem Holding AG-Weaknesses

Bachem Holding AG-Opportunities

Bachem Holding AG-Threats

Bachem Holding AG-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Bachem Holding AG, Recent Deals Summary

Section 5-Company's Recent Developments

Mar 08, 2019: Bachem 2018 fiscal year: record sales and increased operating income

Nov 21, 2018: Bachem Appoints Thomas Meier as COO

Oct 26, 2018: Thomas Meier to become new COO of Bachem Group

Aug 24, 2018: Bachem-first half of 2018: further rise in the net profit

Jul 20, 2018: Bachem: Footprint in Asia

May 04, 2018: Bachem Site in St Helens, Uk, Obtains ISO Certification

Mar 16, 2018: Bachem: Fiscal year 2017-Continued increase in sales, profitability and earnings

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Bachem Holding AG, Performance Chart (2014-2018)

Bachem Holding AG, Ratio Charts

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Bachem Holding AG, Key Facts

Bachem Holding AG, Key Employees

Bachem Holding AG, Key Employee Biographies

Bachem Holding AG, Major Products and Services

Bachem Holding AG, History

Bachem Holding AG, Subsidiaries

Bachem Holding AG, Key Competitors

Bachem Holding AG, Ratios based on current share price

Bachem Holding AG, Annual Ratios

Bachem Holding AG, Annual Ratios (Cont...1)

Bachem Holding AG, Annual Ratios (Cont...2)

Bachem Holding AG, Interim Ratios

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Bachem Holding AG, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Bachem Holding AG, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Clariant International Ltd

Bio-Gate Ag

Mymetics Corp

Celltrion Inc